David Alderman: ASH25 is Live
David Alderman, President and CEO at Molekule Consulting, shared on LinkedIn:
”Silence before the field ruptures again.
First thing you see walking into ASH25.
Black letters on white. Lobby reeks of fresh carpet glue.
Four days in Orlando will break frontline logic, erase durability curves, and force every franchise team to rewrite 2026–2030 tonight.
Hematology never sleeps in December.
Everyone else does.
If you’re here, you feel it in your chest already.
If you’re not, pay attention.
What leaves these halls this week will outlive the building.
We are already live in every lineage that pays the bills.
If today’s late-breakers just detonated your 2027 budget, find us before your competitor does.
ASH25 is live.”
All from ASH25 featured in Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines
-
Dec 5, 2025, 03:45Ardeshir Khademi: A Clinical Lesson on Thrombophilia, Silent Infarcts, and Asking the Right Questions